- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06547593
A Multifaceted Nutrition Intervention for Frailty in the Community Elderly
A Multifaceted Nutrition Intervention for Frailty in the Community Elderly: a Randomized Controlled Trial
With world's older population is rapidly increasing. China's population aging process is also accelerating. Studies have shown that persistent frailty can increase the incidence of negative events in the elderly. However, research on elderly frailty in China is still in its early stages, and existing research in China mainly focuses on the definition of frailty, evaluation tools for frailty, and cross-sectional surveys of small populations. There is currently limited research on interventions.
The MultIfaceted NUtrition inTErvention for Frailty (minute) trial is a randomized, controlled trial to explore the trajectory characteristics and influencing factors of frailty in the community, the impact of nutritional interventions on the developmental trajectory of frailty in the elderly in the community and the management model and appropriate technology for the sustainable intervention of frailty in the elderly based on the community.
A total of 315 frail older adults will be recruited from Beijing. After the screening period, the compliant participants will be randomized to the control group, the nutrition intervention group with the nutrition intervention alone, or the combined nutrition intervention group with combining exercise and nutrition, on a 1:1:1 ratio, for 3 months. The primary outcome is the change in SPPB from the baseline to the end of the study. The change in SPPB as a primary outcome, and frailty status, demographic information, health status, nutrition assessment, comprehensive geriatric assessment status, quality of life, intrinsic capacity, and mental elasticity as secondary outcomes will be measured using validated questionnaires and clinical examinations.
This trial adheres to the Declaration of Helsinki and guidelines of Good Clinical Practice. Signed informed consent will be obtained from all participants. The trial has been approved by the Peking University Institutional Review Board (approval number: IRB00001052-23178). The results will be disseminated through academic conferences and publications in international peer-reviewed journals.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zhaofeng Zhang, Doctor
- Phone Number: 86-10-82801575
- Email: zhangzhaofeng@bjmu.edu.cn
Study Contact Backup
- Name: Rui Fan, Doctor
- Phone Number: 86-10-82801575
- Email: rfcaubj@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China
- Recruiting
- Qingta Community Health Service Center
-
Contact:
- Yaxin Han, postgraduate
- Phone Number: 15850682311
- Email: 2311210115@bjmu.edu.cn
-
Principal Investigator:
- Zhaofeng Zhang, Doctor
-
Sub-Investigator:
- Yaxin Han, postgraduate
-
Sub-Investigator:
- Haohao Zhang, postgraduate
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Frailty assessed by the frail phenotype
- Aged between 65 and 85 years old
Exclusion Criteria:
- Multiple serious diseases such as stroke, cerebral infarction, tumors, and severe cardiovascular and cerebrovascular diseases
- Disability, dementia; severe visual and hearing impairments, and physical activity impairment
- Moderate to severe anxiety and depression
- Unable to complete this study as requested
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nutritional Intervention Group
In this group, based on routine health management, a 3-month multifaceted nutrition intervention and a 9-month follow-up will be conducted. The specific content is as follows:
|
In this group, a 3-month multifaceted nutrition intervention will be conducted. The specific content is as follows:
|
|
Experimental: Nutritional and Exercise Combined Intervention Group
To investigate the combined effects of nutrition and exercise, this group added exercise intervention in addition to the corresponding intervention measures of the nutrition intervention group.
The subjects were required to exercise 3 times a week, 1 hour each time.
The project included 10 minutes of warm-up exercises (stretching), 10-20 minutes of aerobic exercise (balance ability, leg and core muscle strength, etc.), 10-20 minutes of muscle resistance strength training (legs, buttocks, feet, upper limbs, etc.) and 10 minutes of relaxation training.
All exercise programs were uniformly trained by professional coaches, and compliance was ensured by uploading photos to punch the clock.
The intervention period is 3 months, with a follow-up of 9 months.
|
To investigate the combined effects of nutrition and exercise, this group added exercise intervention in addition to the corresponding intervention measures of the nutrition intervention group.
The subjects were required to exercise 3 times a week, 1 hour each time.
The project included 10 minutes of warm-up exercises (stretching), 10-20 minutes of aerobic exercise (balance ability, leg and core muscle strength, etc.), 10-20 minutes of muscle resistance strength training (legs, buttocks, feet, upper limbs, etc.) and 10 minutes of relaxation training.
All exercise programs were uniformly trained by professional coaches, and compliance was ensured by uploading photos to punch the clock.
The intervention period is 3 months, with a follow-up of 9 months.
|
|
Placebo Comparator: Control Group
The control group will undergo routine community health management, including regular chronic disease health education lectures, provision of health education materials, health counseling services, and comprehensive health examinations by qualified medical professionals. At the beginning and end of the intervention, as well as at a 9-month follow-up, the study subjects were evaluated to understand the sustainability of the intervention after the project was completed, and to explore the management mode of sustainable intervention. |
The control group will undergo routine community health management, including regular chronic disease health education lectures, provision of health education materials, health counseling services, and comprehensive health examinations by qualified medical professionals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Physical Performance Battery (SPPB) score
Time Frame: at the 3-month intervention and at the 3-month, 6-monthand 12-month follow-up investigations
|
The primary outcome was the change in the Short Physical Performance Battery (SPPB) score between groups, and the change from baseline to the end of the study.
|
at the 3-month intervention and at the 3-month, 6-monthand 12-month follow-up investigations
|
|
frailty scores
Time Frame: at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
The frailty scores were evaluated using Fried Frailty Phenotype and Tilburg Frailty Indicator
|
at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
frailty trajectories
Time Frame: at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
Changes in frailty trajectories before and after the intervention, as measured by the Frailty Index.
|
at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
|
intrinsic capacity
Time Frame: at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
Changes in intrinsic capacity before and after the intervention, and between groups; The intrinsic capacity is measured using the World Health Organization's (WHO) Integrated Care for Older People (ICOPE) approach.
|
at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
|
Malnutrition risk assessment
Time Frame: at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
Measured by 《Malnutrition Risk Assessment Form for the Elderly》
|
at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
|
frailty recovery rates
Time Frame: at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
Difference in frailty scores before and after intervention
|
at the 3-month intervention and at the 3-month, 6-month and 12-month follow-up investigations
|
|
Serum protein
Time Frame: at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
serum total protein, albumin and transferrin
|
at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
|
Urine 8-hydroxyguanosine (8-oxo-Gsn)
Time Frame: at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
Urine oxidation marker 8-hydroxyguanosine (8-oxo-Gsn) level
|
at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
|
Serum inflammatory factors
Time Frame: at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor - α (TNF - α), insulin-like growth factor-1 (IGF-1), C-X-C-motif chemokine 10 (CXCL10), chemokine C-X3-C-based ligand 1 (CX3CL1) in serum using ELISA
|
at the 3-month intervention and at the 3-month and 12-month follow-up investigations
|
|
changes in serum differential metabolites
Time Frame: At the beginning of the intervention and in the third month of the intervention
|
Using non targeted metabolomics methods to examine the changes in serum differential metabolites in each group before and after intervention, and elucidate the mechanism of intervention
|
At the beginning of the intervention and in the third month of the intervention
|
|
changes in gut microbiota
Time Frame: At the beginning of the intervention and in the third month of the intervention
|
Using 16S sequencing method to detect changes in gut microbiota and differential bacterial genera among groups
|
At the beginning of the intervention and in the third month of the intervention
|
|
participants' satisfaction
Time Frame: At the beginning of the intervention and in the third month of the intervention
|
participants satisfaction and acceptability is evaluated using a self-made scale
|
At the beginning of the intervention and in the third month of the intervention
|
|
cognition function
Time Frame: at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
cognition function is evaluated using Mini-Mental State Examination, MMSE
|
at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
|
Sleep conditions
Time Frame: at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
Sleep conditions is evaluated using Pittsburgh sleep quality index
|
at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
|
adverse event
Time Frame: at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
serious adverse events, unexpected adverse events, and adverse events that occurred while the participant was under the supervision or guidance of study staff either onsite or offsite.
|
at the 3-month intervention and at the 6-month and 12-month follow-up investigations
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zhaofeng Zhang, Doctor, Peking University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MINUTE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elderly
-
University of Rome Foro ItalicoEnrolling by invitationAging | Elderly | Frail Elderly | Aging Frailty | Sarcopenia in ElderlyItaly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
University of ThessalyCompletedFunctionality, Falls, Elderly, Fall Prevention, Exercise Elderly, Assessment, Rehabilitation, Community-DwellingGreece
-
Indian Council of Medical ResearchSt Johns Medical College Hospital, Bangalore, IndiaRecruiting
-
Burdur Mehmet Akif Ersoy UniversityPamukkale UniversityCompleted
-
Hospital Israelita Albert EinsteinConselho Nacional de Desenvolvimento Científico e Tecnológico; Paulo de Tarso...Completed
-
Istanbul Medipol University HospitalCompleted
-
Seoul National University HospitalCompleted
-
Purdue UniversityCompleted
Clinical Trials on multifaceted nutrition intervention
-
University of TorontoCanadian Institutes of Health Research (CIHR)Completed
-
Third Affiliated Hospital, Sun Yat-Sen UniversitySir Run Run Shaw Hospital; The First People's Hospital of Hefei; The Second Affiliated... and other collaboratorsRecruiting
-
National Taiwan University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedGlobal Medical Assessment of Elderly Frail PatientsFrance
-
Aga Khan UniversityImperial College London; Wellcome TrustCompletedOccupational Diseases | Occupational Lung DiseasePakistan
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedAdverse Drug ReactionBrazil
-
McGill UniversityCompleted
-
Maastricht University Medical CenterThe Netherlands Asthma FoundationCompletedObesity | Overweight | AsthmaNetherlands
-
Pontificia Universidad Catolica de ChileAgencia Nacional de Investigacion y Desarrollo, ANIDCompleted